NemaGen Discoveries is an early phase biotech company focused on advancing therapies for patients suffering from allergic inflammation and mast cell-related diseases.
NemaGen's novel technologies were developed by investigating the body's natural ability to prevent unwanted inflammation following parasitic infections. By taking this unique approach NemaGen has pioneered first-in-class therapeutic strategies to help patients suffering from diverse inflammatory diseases.
Please email us for more information regarding our novel technologies or exciting employment opportunities.